T-DM1 Overall Survival Data Released, FDA Grants Priority Review

Breast Cancer News
January 24, 2013
By: 
Josh Fernandez, Digital Media Specialist
Reviewed By: 
Julie R. Gralow, MD
You must have Javascript enabled to use this form.

More In Targeted Therapy

Additional Related Topics 
HER2-Positive
Clinical Trials
Chemotherapy